StockData
Cellyan Biotechnology Co., Ltd logo

Cellyan Biotechnology Co., Ltd (HKPD) stock

HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$1.52−0.09 (-5.30%)

Close on Nov 17, 2026Market cap $24.93MP/E –Yield –

Cellyan Biotechnology gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2026 it was 10.3%, against 11.9% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026Mar 31, 202610.3%−1.6
FY2025Mar 31, 202511.9%−9.4
FY2024Mar 31, 202421.3%−0.5
FY2023Mar 31, 202321.8%–

More Cellyan Biotechnology figures

See a number that looks wrong?